Dr. Thomas E. Schryver

Paul Armstrong is a Cardiologist in Forest Hill, Maryland. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Acute Coronary Syndrome, Heart Attack, Heart Failure, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Armstrong is currently accepting new patients.

Dr. Chao-Wei Hwang is an interventional cardiologist and Assistant Professor of Medicine at Johns Hopkins. Dr. Hwang received doctoral and medical training at Harvard Medical School. He completed residency in Internal Medicine at Brigham and Women's Hospital, and Cardiology and Interventional Cardiology fellowships at The Johns Hopkins Hospital. Dr. Hwang joined the Division of Cardiology as faculty in 2011. He spent a year at Virtua Health System in New Jersey as systemwide Director of Interventional Cardiology, and is now Director of the Johns Hopkins Interventional Cardiology Program at Frederick Health Hospital (FHH) and Co-Medical Director of the FHH Cardiac Catheterization Lab. Dr. Hwang is an expert interventional cardiologist specializing in complex coronary interventions, management of acute coronary syndromes and advanced coronary artery disease. He has specialized expertise in PCI of chronic total occlusions (CTO). Dr. Hwang has been involved in a number of device and coronary clinical trials, and his broad areas of research interests include developing and optimizing devices for the treatment of coronary artery disease. Dr. Hwang has published extensively in stent-based drug delivery systems and local delivery systems for cell-based therapies to the heart. Dr. Hwang is rated as a Distinguished provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Angioplasty, and Percutaneous Coronary Intervention (PCI).

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Heart Attack. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).